CLINICAL_TRIALS trial_result · 2012-12-26

Clinical Trial Update: Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype [Phase 3]

Phase 3 trial evaluating a genotype-guided, tailored smoking cessation treatment algorithm; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Duke University | Conditions: Smoking Cessation | Phase 3 | Status: COMPLETED | Results posted: 2012-12-26